Categories

R&D Ashes: Is the UK Losing the Series?

Recently I spoke with two international businesses, one Dutch and one Korean. Both were involved in oncology clinical trials. Both were deciding where to run the next phase of development.

Read More

R&D Tax Relief in 2025 review

As 2025 draws to a close, it is clear that this has been one of the most consequential years for UK R&D tax relief since the original SME and RDEC

Read More

R&D in the 2025 Budget

The 2025 Budget makes it clear that research and development remains central to the United Kingdom’s growth strategy. There are no dramatic headline changes to R&D tax relief rates. However,

Read More